Healthcare private equity had another banner year, topping off a remarkable decade. Whatever macroeconomic risks simmered in 2019—from slowing economies to ongoing or debated regulatory reforms – they did not temper investor enthusiasm for this resilient sector. Deal count may have remained flat compared with 2018, but disclosed deal value rose markedly. Similarly, corporate M&A disclosed deal value rose to an all-time high on the back of two megamergers. Exits were steady and holding periods remained low as portfolios returned to healthier positions. Bain’s annual report looks at recent trends and the outlook for healthcare investing.
Read the full article: Global Healthcare Private Equity and Corporate M&A Report 2020 //